NUFARM LIMITED
February 2026's Global Undervalued Small Caps With Insider Activity
As we enter February 2026, global markets are navigating a complex landscape marked by steady interest rates from the Federal Reserve and mixed performances across major indices, with small- and mid-cap stocks underperforming their larger counterparts. Amid these conditions, identifying promising small-cap opportunities often involves looking for companies that can thrive despite broader economic challenges and exhibit signs of potential growth through strategic insider activity.
Source: Simply Wall St. Feb 4, 2026
Shareholders in Nufarm (ASX:NUF) are in the red if they invested three years ago
While not a mind-blowing move, it is good to see that the Nufarm Limited ( ASX:NUF ) share price has gained 10% in the...
Source: Simply Wall St. Feb 2, 2026
3 Top Undervalued Small Caps In Global With Insider Buying
As global markets navigate a mixed start to the year, with U.S. stocks experiencing slight declines and European indices reaching new highs, small-cap stocks continue to draw attention amid these dynamic conditions. In this environment, identifying promising opportunities in small-cap companies often involves looking for those with strong fundamentals and potential insider confidence, which can be indicative of alignment between management interests and shareholder value.
Source: Simply Wall St. Jan 6, 2026
Exploring Global's Undervalued Small Caps With Insider Buying December 2025
As global markets navigate the final month of 2025, investor sentiment is buoyed by hopes for an interest rate cut from the Federal Reserve, with small-cap stocks like those in the Russell 2000 Index experiencing a modest rise. Despite challenges such as contracting manufacturing activity and fluctuating employment figures, opportunities arise in identifying small-cap companies that demonstrate resilience and potential value through strategic insider investments. In this context,...
Source: Simply Wall St. Dec 8, 2025
Assessing Nufarm’s (ASX:NUF) Valuation After Deep FY25 Loss and Upcoming Leadership Change
Nufarm (ASX:NUF) just posted a statutory net loss of $165 million for fiscal 2025, mainly due to hefty non-cash charges from its Seed Technologies and plant-based omega-3 businesses. Investors are now watching closely as leadership changes are expected. See our latest analysis for Nufarm. It has been a volatile year for Nufarm shareholders. While the latest 7-day and 30-day share price returns are in double digits, the bigger picture is far less rosy, with the year-to-date share price down...
Source: Simply Wall St. Nov 22, 2025
Nufarm Limited (ASX:NUF) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
It's been a pretty great week for Nufarm Limited ( ASX:NUF ) shareholders, with its shares surging 15% to AU$2.56 in...
Source: Simply Wall St. Nov 20, 2025
- Herbicides
- Pesticides
- Seeds
- Fertilizers
- Soil conditioners
- Compost
- Manure
- Agricultural chemicals
- Basic chemicals
- Industrial inorganic chemicals
- Chemicals and allied products
- Nondurable goods
- Farming equipment
- Agricultural machinery
- Tractors
- Harvesting machinery
- Plows
- Cultivators
- Sprayers
- Dusting machines
- Fertilizer spreaders
- Seeders
- Parts for agricultural machinery
- Livestock
- Livestock feed
- Veterinary medicines
- Veterinary equipment
- Irrigation equipment
- Greenhouse equipment
- Mulch
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.
All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.
